Latest News

Emergency gout admission increase is ‘call to arms’


 

AT RHEUMATOLOGY 2018

Pages

Recommended Reading

For acute gout, corticosteroids look safer than NSAIDs
MDedge Internal Medicine
FDA approves once-daily treatment for hyperuricemia in gout
MDedge Internal Medicine
Allopurinol extension trial backs treat-to-target approach in gout
MDedge Internal Medicine
Febuxostat prevents early gout flares
MDedge Internal Medicine
Gout incidence is intertwined with serum urate, but only up to a point
MDedge Internal Medicine
FDA: Febuxostat may have increased heart-related death risk
MDedge Internal Medicine
Higher water intake linked to less hyperuricemia in gout
MDedge Internal Medicine
Health disparities in rural America: Chronic conditions
MDedge Internal Medicine
Febuxostat increases cardiovascular mortality in CARES trial
MDedge Internal Medicine
Allopurinol dose not escalated enough to reduce mortality
MDedge Internal Medicine

Related Articles